A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT
- Status
- COMPLETED
- Phase
- NA
Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2
- Status
- RECRUITING
- Phase
- PHASE3
A Patient-centered Communication Tool (UR-GOAL) for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists
- Status
- COMPLETED
- Phase
- NA
Sabatolimab as a Treatment for Patients With Acute Myeloid Leukemia and Presence of Measurable Residual Disease After Allogeneic Stem Cell Transplantation.
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
FT538 in Subjects With Advanced Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Pharmacokinetics of Venetoclax in Patients With Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- N/A
A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
IL3 CAR-T Cell Therapy for Patients With CD123 Positive Relapsed and/or Refractory Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Prospective and Retrospective Observational Evaluation of Real World Outcome of Unfit AML Patients Treated With the Combination Venetoclax Plus Hypomethylating Agents, Under the Italian Law No.648/96
- Status
- COMPLETED
- Phase
- N/A
Study to Evaluate the Safety and Tolerability of EP0042
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7283420.
- Status
- COMPLETED
- Phase
- PHASE1
Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE3
RN-Led Palliative and Supportive Care Intervention
- Status
- COMPLETED
- Phase
- NA
Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers
- Status
- TERMINATED
- Phase
- PHASE1
A Study of PRT1419 in Patients With Relapsed/Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease
- Status
- TERMINATED
- Phase
- PHASE2
TP-0903 for the Treatment of FLT3 Mutated Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Could Ki-67 be Used as a Diagnostic or Prognostic Marker in Hemato-oncological Diagnostics?
- Status
- UNKNOWN
- Phase
- N/A